AnemoCheck-LRS: an optimized, color-based point-of-care test to identify severe anemia in limited-resource settings.
Perez-Plazola, MS; Tyburski, EA; Smart, LR; Howard, TA; Pfeiffer, A; Ware, RE; Lam, WA; McGann, PT.
BMC Medicine.
2020;
18.
Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease.
George, A; Dinu, B; Estrada, N; Minard, CG; Hurwitz, R; Mahoney, DH; Yates, AM; Vaughan, M; Carmouche, A; Airewele, G; et al.
American Journal of Hematology.
2020;
95:E242-E244.
Hydroxyurea Exposure in Lactation: a Pharmacokinetics Study (HELPS).
Ware, RE; Marahatta, A; Ware, JL; McElhinney, K; Dong, M; Vinks, AA.
The Journal of Pediatrics.
2020;
222:236-239.
β-Thalassemia pathogenic variants in a cohort of children from the East African coast.
Macharia, AW; Mochamah, G; Uyoga, S; Ndila, CM; Nyutu, G; Tendwa, M; Nyatichi, E; Makale, J; Ware, RE; Williams, TN.
Molecular Genetics and Genomic Medicine.
2020;
8.
Empowering newborn screening programs in African countries through establishment of an international collaborative effort.
Jr, TB L; Lloyd-Puryear, MA; Ohene-Frempong, K; Ware, RE; Padilla, CD; Ambrose, EE; Barkat, A; Ghazal, H; Kiyaga, C; Mvalo, T; et al.
Journal of Community Genetics.
2020;
11:253-268.
Hydroxyurea dose escalation for sickle cell Anemia in sub-Saharan Africa.
John, CC; Opoka, RO; Latham, TS; Hume, HA; Nabaggala, C; Kasirye, P; Ndugwa, CM; Lane, A; Ware, RE.
The New England journal of medicine.
2020;
382:2524-2533.
Hydroxyurea to lower transcranial Doppler velocities and prevent primary stroke: The Uganda NOHARM sickle cell anemia cohort.
Opoka, RO; Hume, HA; Latham, TS; Lane, A; Williams, O; Tymon, J; Nakafeero, M; Kasirye, P; Ndugwa, CM; John, CC; et al.
Haematologica: the hematology journal.
2020;
105:e272-e275.
Effective use of hydroxyurea for sickle cell anemia in low-resource countries.
Power-Hays, A; Ware, RE.
Current Opinion in Hematology.
2020;
27:172-180.
Perceived benefits and risks of participation in a clinical trial for Ugandan children with sickle cell anemia.
Carman, AS; Sautter, C; Anyanwu, JN; Ssemata, AS; Opoka, RO; Ware, RE; Rujumba, J; John, CC.
Pediatric Blood and Cancer.
2020;
67.
Zinc for Infection Prevention in Sickle Cell Anemia (ZIPS): study protocol for a randomized placebo-controlled trial in Ugandan children with sickle cell anemia.
Datta, D; Namazzi, R; Conroy, AL; Cusick, SE; Hume, HA; Tagoola, A; Ware, RE; Opoka, RO; John, CC.
Trials.
2019;
20.